These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9593014)

  • 41. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations.
    Fishbein DB; Dreesen DW; Holmes DF; Pacer RE; Ley AB; Yager PA; Sumner JW; Reid-Sanden FL; Sanderlin DW; Tong TC
    Vaccine; 1989 Oct; 7(5):437-42. PubMed ID: 2815979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.
    Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N
    Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines.
    Albas A; Pardo PE; Gomes AA; Bernardi F; Ito FH
    Rev Soc Bras Med Trop; 1998; 31(4):367-71. PubMed ID: 9662964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children.
    Janewongwirot P; Jantarabenjakul W; Anugulruengkitt S; Anunsittichai O; Saengseesom W; Buranapraditkun S; Sophonphan J; Wacharachaisurapol N; Jitrungruengnij N; Pancharoen C; Puthanakit T
    Vaccine; 2019 Aug; 37(36):5307-5313. PubMed ID: 31358408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study.
    Quiambao B; Montalban C; Minutello AM; Guinet-Morlot F; Moureau A; Petit C; Pichon S
    Vaccine; 2022 Aug; 40(35):5170-5178. PubMed ID: 35906106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pre-exposure rabies vaccination using a new duck embryo vaccine].
    Bachmann G; Steffen R; Glück R; Wegmann A; Schär M
    Schweiz Med Wochenschr; 1985 Jun; 115(25):863-5. PubMed ID: 4023675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
    Vien NC; Feroldi E; Lang J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
    Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
    Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.
    Kositprapa C; Limsuwun K; Wilde H; Jaijaroensup W; Saikasem A; Khawplod P; Kri-aksorn U; Supich C
    Clin Infect Dis; 1997 Sep; 25(3):614-6. PubMed ID: 9314448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization.
    Dreesen DW; Fishbein DB; Kemp DT; Brown J
    Vaccine; 1989 Oct; 7(5):397-400. PubMed ID: 2815976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of human immune responses to purified Vero cell and human diploid cell rabies vaccines by using two different antibody titration methods.
    Kitala PM; Lindqvist KJ; Koimett E; Johnson BK; Chunge CN; Perrin P; Olsvik O
    J Clin Microbiol; 1990 Aug; 28(8):1847-50. PubMed ID: 2203814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One year booster vaccination with purified vero cell rabies vaccine.
    Suntharasamai P; Chanthavanich P; Supanaranond W; Warrell MJ
    Trans R Soc Trop Med Hyg; 1988; 82(4):633. PubMed ID: 3256120
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy.
    Strady C; Jaussaud R; Béguinot I; Lienard M; Strady A
    Vaccine; 2000 Jun; 18(24):2661-7. PubMed ID: 10781852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
    Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.